Live
- Calcutta High Court stays order on demolition of hotels in Bengal’s Mandarmani
- AP Legislative Council Approves Key Bills
- WhatsApp Update: WhatsApp Rolls Out Group Mentions in Status Updates
- Czech PM, European Council President-elect discuss cooperation, EU priorities
- 47 killed, 22 injured in Israeli airstrikes on Lebanon's Baalbek-Hermel
- Chandrababu Advocates for Balanced Governance and Development in Andhra Pradesh
- Our 6 free services in Delhi pinching rivals: Kejriwal at 'Revadi par Charcha' campaign
- Abu Dhabi T10: Jos Buttler shines in debut, lauds England batters after memorable performances
- BCCI releases dates for IPL 2025 to 2027
- Centre releases Rs 448 crore as grant for rural local bodies in Karnataka
Aurobindo recalls Lidocaine injections from US
Aurobindo Pharma Ltd has initiated recall of 88,600 vials of Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL) from the US market as one of the vials contained a strand of hair, the US Food and Drug Administration said.
Hyderabad: Aurobindo Pharma Ltd has initiated recall of 88,600 vials of Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL) from the US market as one of the vials contained a strand of hair, the US Food and Drug Administration said.
According to a notification put up by the US Drug regulator in its website, these vials were manufactured in India for AuroMedics Pharma LLC.
"Reason for Recall: Presence of Particulate Matter: One vial was found to contain a hair," it said.
Lidocaine HCl injection is a medication used for local or regional anaesthesia to perform certain surgeries and procedures.
The Product is being held at a distributor site in Mexico, Asheboro and Charlotte, North Carolina, and Santa Teresa, New Mexico and not further distributed in the US Market, the FDA notification said.
